Abstract
Improvement of the yield of plant therapeutic compounds through conventional breeding, in vitro tissue culture, hairy-root culture, cell-suspension culture, and total organic synthesis is still a challenge. However, recent achievements have been made in the metabolic engineering of plant secondary metabolites biosynthesis in medicinal plants and microbes. Metabolic engineering techniques are being employed to overexpress genes coding for enzymes associated with the rate limiting steps of biosynthesis of plant therapeutics or inhibit the enzyme of other pathways competing for their precursors. Metabolic engineering of plant therapeutics biosynthesis has been studied in various medicinal plants and microbes aiming at increasing yield in the past few years. Combinatorial metabolism is a new tool in the generation of novel natural products and for the enhanced production of rare and expensive natural products. The basic concept is combining metabolic pathways in different organisms on a genetic level. As a consequence heterologous organisms provide precursors from their own primary and secondary metabolism that are metabolized to the desired secondary product due to the expression of foreign genes. These strategies which could be employed to enhance the yield of plant therapeutic compounds in both in vitro and in vivo are discussed in this chapter.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Medicinal and Aromatic Plants: Expanding their horizons through Omics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.